Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The use of remifentanil during general anesthesia for caesarean section

Van de Velde, Marc

Current Opinion in Anesthesiology: June 2016 - Volume 29 - Issue 3 - p 257–260
doi: 10.1097/ACO.0000000000000334
OBSTETRICS AND GYNECOLOGICAL ANESTHESIA: Edited by Marc Van de Velde
Buy

Purpose of review The purpose is to review the neonatal and maternal effects of remifentanil given at induction of general anesthesia for caesarean section and prior to delivery of the baby.

Main findings Remifentanil seems to have short-lived respiratory depressant effects in approximately 50% of neonates, requiring short periods of mask ventilation or tactile stimulation of the neonate. Remifentanil produces excellent maternal hemodynamic stability avoiding tachycardia and hypertension, possibly reducing the risk of maternal awareness.

Summary Remifentanil can be safely used at induction of general anesthesia provided healthcare workers are available to manage short-lived neonatal depression.

Department of Cardiovascular Sciences, Department of Anesthesiology, UZ Leuven, KU Leuven, Leuven, Belgium

Correspondence to Marc Van de Velde, MD, PhD, EDRA, Professor of Anesthesiology, Department of Cardiovascular Sciences, Section Anaesthesiology, Catholic University Leuven, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Tel: +0032 16 34 42 70; fax: +0032-16 34 42 45; e-mail: marc.vandevelde@uzleuven.be

Copyright © 2016 YEAR Wolters Kluwer Health, Inc. All rights reserved.